Introduction
Dental pulp revascularization has been widely applied in dental clinics and has been demonstrated to promote the continuous root development of necrotic immature teeth. 1, 2, 3 The formation of a high-quality blood clot in a root canal was considered a key point in dental pulp revascularization. The blood clot acts as a biological scaffold for regenerative endodontic treatments and affects the prognosis of treated teeth. 4, 5 However, in some cases, high-quality blood clots cannot be formed in the root canal space, which may lower the success rate of pulp revascularization. 6 In recent years, platelet concentrates have been used as scaffold materials to compensate for the lack of high-quality blood clots and to increase the success rate. 7, 8, 9 Currently, new generations of platelet concentrates are being developed and applied in the dental clinic. Concentrated growth factor (CGF), the newest product, contains abundant growth factors, such as platelet-derived growth factor (PDGF), chemokine receptor 4 (CXCR4), vascular endothelial growth factor (VEGF), fibroblast growth factor, and insulin-like growth factors. 10 In addition, CGF lacks the cell components of whole blood, avoiding the risk of infectious disease. CGF represents natural scaffolds with the potential to accelerate tissue repair; 11, 12 therefore, we speculated that CGF can improve the prognosis of dental pulp revascularization. A key factor is that newly formed blood vessels grow into the root canal and provide oxygen and nutrients for dental pulp revascularization. However, the angiogenic effects of CGF on dental pulp revascularization are rarely discussed. Thus, the present study aimed to evaluate the angiogenic effects of CGF on dental pulp cells(DPCs) and endothelial cells at the cellular and molecular biological level.
Methodology Preparation of concentrated growth factor extracts (CGFe)
This study was approved by the Institutional Research Ethics Committee of Chongqing Medical University, Chongqing, China (4th April, 2016; CQHS-IRB-2016-04) , and informal consents were acquired from donors. Venous blood was obtained from three healthy, nonsmoking male volunteers (age range of 35-40 years). As described in a previous study, 13 peripheral blood was collected and immediately centrifuged by a Medifuge centrifugation system (Silfradent, Italy). CGF clots isolated from the three blood samples were mixed, placed on gauze to eliminate excess serum and transferred to freezing tubes. CGF clots were minced, homogenized, stored at -80°C for 1 h, and then centrifuged at 3000 rpm for 10 min at room temperature. The supernatants (CGFe) were filtered by a 0.22 μm sterile syringe filter (Solarbio, China) and then stored at -80°C until use. The final CGFe concentration (2%, 5%, 10% and 15%) in the experimental groups was calculated on the basis of the volume of CGFe that was added to the total volume of culture medium containing 10% fetal bovine serum (FBS). The control group only received 10% FBS.
Cell culture
Human umbilical vein endothelial cells (HUVECs) were purchased from Chongqing Baersi Biotechnology Corporation and were cultured in Dulbecco's modified Eagle's medium (DMEM) with 10% FBS containing 100 U/mL penicillin and 100 mg/mL streptomycin in a cell incubator at 5% CO 2 and 37°C.
DPCs were isolated from the premolars of a 13-yearold patient that were extracted for orthodontic purposes using the method described by Ma et al. 14 Only 5th generation dental pulp cells were used for experiments. The cells were cultured in DMEM (high glucose) with 10% FBS containing 100 U/mL penicillin and 100 mg/ mL streptomycin in an incubator at 37 °C and 5% CO 2 .
Cell proliferation assay
Cells (DPCs and HUVECs) were seeded in a 96-well plate at a density of 3 x 10 3 cells per well and treated with different concentrations of CGFe or FBS. After culturing for 0 h, 12 h, 24 h, and 36 h at 37°C and 5% CO 2 , the cell proliferation rates were determined with CCK-8 (Solarbio, China) using a microplate reader (Bio-Rad, Hercules, USA) at a wavelength of 450 nm. Eight repetitive wells were used for each group, the maximum and minimum values were excluded, and the remaining data were used for statistical analysis.
Cell cycle analysis
DPCs were seeded in a 6-well plate at a density of 2 x 10 5 cells per well. After overnight serum starvation, the DPCs were incubated in a cell incubator and treated with different concentrations of CGFe or FBS for 24 h. Then, the DPCs were fixed with precooled 70% ethanol at 4 °C overnight. The cell cycle was evaluated using a cell cycle kit (Solarbio, China) according to the manufacturer's instructions. Cell samples were analyzed by flow cytometry (BD, USA), and data were analyzed using Modfit LT 4.1 software (Verity Software House, USA).
Transwell migration assay
A migration assay was performed using a 12-well Transwell chamber plate (4 µm pore size, Corning) following the manufacturer's protocol. HUVECs were seeded in triplicate in the upper compartment of the chamber (10 X 10 4 cells/500 µl per well). The lower compartment was filled with 1.5 mL of cell culture medium containing different concentrations of CGFe or FBS. After culturing for 6 h at 37 °C and 5% CO 2 , the cells that migrated through the polycarbonate membrane were fixed with methanol for 20 min and then stained with crystal violet for 15 min. The cells were photographed under a microscope with a digital imaging system (Nikon, Japan) and counted.
In vitro tube formation assay
Matrigel (BD, USA) was thawed at 4°C overnight and then coated on the bottom of a 96-well plate (50 µl per well) at 37°C for 1 h. The endothelial cells (1X10 4 cells/200 µl per well) suspended in medium containing different concentration of CGFe or FBS were added to the matrigel and cultured at 37°C and 5% CO 2 for 4-18 h. Vessel tube-like structures were observed and photographed under a microscope with a digital imaging system (Nikon, Japan). Then, the data were analyzed using ImagePro Plus software.
Quantitative real-time PCR
Total RNA was isolated from DPCs using RNAiso plus reagent (Takara, Japan). cDNA was synthesized by the use of a RevertAid Reverse Transcription Kit (Thermo Scientific, China) and then analyzed by the use of a real-time PCR system (Bio-Rad, USA). The reaction conditions were as follows: preannealing at a temperature of 9 °C for 30 s; annealing at temperatures of 95°C for 5 s and 6 °C for 34 s for 40 cycles. Expression values were normalized to GAPDH. The sequences of CXCR4, PDGF, VEGF and GAPDH are detailed in Table. Western blotting DPCs were cultured with cell culture media with 2%, 5%, and 10% CGFe and without CGFe. After 24 h of culture, the cell samples were lysed in RIPA lysis buffer (Beyotime, China). Protein concentrations were measured using a BCA protein kit (Beyotime, China). Twenty microliters of protein was loaded per lane on a 10% SDS-PAGE gel for electrophoresis and then transferred to 0.22 mm PVDF membranes (Bio-Rad, USA). Western blot analysis was performed as described previously. 15 
Statistical analysis
Data were calculated and expressed as the mean and standard error. Statistical analysis was performed using SPSS 22.0 software. Statistical significance was evaluated by using one-way analysis of variance (ANOVA) followed by Tukey's multiple comparison test. A p-value < 0.05 was considered significant.
Results

Effects of CGFe on cell proliferation in DPCs
DPCs cultured with CGFe had significantly higher proliferation rates than the control group (p < 0.05) ( Figure 1A ). Higher concentrations (≤ 10%) of CGFe allowed faster cell growth; however, the 15% CGFe concentration showed the same proproliferative effects as 10% CGFe at all time points (p > 0.05). Thus, the 15% CGFe group was not used in the other assays.
The cell cycle assay showed that G2/M phase cell ratio significantly increased after culture with CGFe (p < 0.05) ( Figure 1B) . The cell proliferation capacities of the different groups on were as follows: control group<2% CGFe group < 5% CGFe group < 10% CGFe group.
Effects of CGFe on HUVEC proliferation and migration
HUVEC proliferation and migration are two key aspects of revascularization. The CCK-8 assay showed that HUVECs had higher proliferation rates after CGFe treatment at all measured time point and that the higher concentrations allowed faster cell growth (Figure 2A , p < 0.05). Representative images of transwell Figure 2B and the results showed that CGFe promoted HUVECs migration at 2%, 5%, 10% concentrations and the enhancement peaked at 10% ( Figure 2C , p < 0.05). This result indicated that the proproliferative and promigratory effects of CGFe were dose dependent for concentrations of ≤ 10%.
Effects of CGFe on in vitro tube formation
The cells seeded on matrigel began to form vessellike structures after 4 h. Treatment with CGFe led to a significant increase in the quantity of tube formation compared with that in the control group and had a positive dose-dependent effect on vessel-like structure formation (p < 0.05) (Figure 3) . Effects of CGFe on the PDGF, CXCR4 and VEGF mRNA levels of DPCs
To explore the effect of CGFe treatment on DPCs at the mRNA level, we compared the mRNA expression of PDGF, CXCR4, and VEGF using RT-PCR. The mRNA expression levels of PDGF, CXCR4, and VEGF in the experimental group were upregulated compared with those in the control group, and the expression increased in a positive dose-dependent manner (p < 0.05) (Figure 4 ).
Effects of CGFe on the levels of related proteins in DPCs
The VEGF and CXCR4 protein levels in DPCs were determined by Western blot. The expression levels of both VEGF and CXCR4 in the three experimental groups were upregulated after 24 h compared with those in the control group, and these expression levels also increased in a positive dose-dependent manner (p < 0.05) ( Figure 5 ).
Discussion
Concentrated growth factor (CGF), a kind of fibrin plasma rich in growth factors, has been clinically shown to accelerate tissue healing in many fields, such as bone reconstruction, angiogenesis, dental implants and other types of tissue remodeling. The platelets in CGF are 15.5 times as concentrated as in those in whole blood according to Masuki et al. CGF contains high concentrations of growth factors, including PDGF, VEGF, and CXCR4. VEGF is the most potent cytokine involved in angiogenesis. 15 The regulation of VEGF is critical to neovascularization in numerous tissues under both physiological and pathological conditions. 16 Studies showed that VEGF played a key role in the differentiation of dental pulp stem cells into endothelial cells. 17 VEGF also promotes the survival and proliferation of endothelial cells and the sprouting and permeability of vessels. 16, 18, 19 In addition, CXCR4 was also proved to play an important role 20 in regulating angiogenesis through interaction with its ligand, 21, 22, 23 by recruiting endothelial progenitor cells. 24, 25, 26 PDGF, a powerful angiogenic growth factor, had synergistic and composite effects with other cytokines involved in the angiogenic effects. 27 A study by Zhang et al. 28 proved that PDGF possesses the powerful function of inducing dentin-pulp tissue regeneration by dental pulp stem cells. Therefore, we speculated that these growth factors in CGF will promote dental pulp revascularization. DPCs are considered the main cells for regenerative endodontics. 29, 30, 31 Some living DPCs still exist in the apical region of dental pulp even in teeth that suffer from irreversible pulpitis. DPCs were also demonstrated to interact with endothelial cells to enhance angiogenic effects in vitro. 31, 32, 33 Endothelial cell proliferation and migration are essential events during angiogenesis. 15 Therefore, the proliferation and differentiation of DPCs and the proliferation, migration and vascular structure formation capacity of HUVECs were evaluated in our experiment. Based on the results of our study, CGFe elevated the VEGF, PDGF and CXCR4 expression of DPCs, promoted HUVEC proliferation and migration and augmented vascular structure formation, suggesting that CGF plays a significant positive role in dental pulp revascularization.
However, higher concentrations of CGFe do not guarantee stronger promoting effects. In our study, CGFe at concentrations ≤10% promoted cell proliferation and enhanced angiogenesis in a dose-dependent manner. However, 15% CGFe showed the same effect on DPC proliferation as 10% CGFe at all time points (p > 0.05), suggesting that the promoting effects of CGFe depend on the concentration used. In a study by Honda et al., 34 CGFe at concentrations below 10% promoted the proliferation and maturation of human bone marrow stromal cells in a dose-dependent manner but had an inhibitory effect at a 20% concentration. An in vitro experiment by Masuki et al. 10 suggested that the proproliferative and promigratory effects of CGFe on periosteal cells peaked at a 10% concentration and that the effects were reversed at a 20% concentration. In study by Qiao et al., 35 the optimum concentration for human periodontal ligament cell proliferation was medium rather than high. A reasonable explanation for this phenomenon might be that CGFe contains not only growth factors that favor revascularization but also antiangiogenic cytokines. 36 At high concentrations, the inhibitory effects of the inflammatory cytokines in CGF might play a dominant role. Previous studies also demonstrated that platelets store proangiogenic and antiangiogenic regulators in separate granules and differentially release these factors in response to different stimuli. 37, 38, 39, 40 Thus, the CGF state may affect the angiogenic capacity of CGF under different conditions, which needs to be further studied.
Based on the results of the present study, CGF shows positive proangiogenic effects on DPCs and HUVECs, which may be an indication of its applicative potential for inducing dental pulp revascularization. The effectiveness of CGF application in dental pulp revascularization needs to be investigated in in vivo studies in the future.
Conclusions
Our study demonstrated that CGF promoted DPC proliferation and differentiation and promoted HUVEC proliferation, migration and vessel-like structure formation.
